Cargando…

Pyrazolo[4,3-c]pyridine Sulfonamides as Carbonic Anhydrase Inhibitors: Synthesis, Biological and In Silico Studies

Carbonic anhydrases (CAs, EC 4.2.1.1) catalyze the essential reaction of CO(2) hydration in all living organisms, being actively involved in the regulation of a plethora of patho-/physiological conditions. A series of chromene-based sulfonamides were synthesized and tested as possible CA inhibitors....

Descripción completa

Detalles Bibliográficos
Autores principales: Angeli, Andrea, Kartsev, Victor, Petrou, Anthi, Lichitsky, Boris, Komogortsev, Andrey, Pinteala, Mariana, Geronikaki, Athina, Supuran, Claudiu T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955975/
https://www.ncbi.nlm.nih.gov/pubmed/35337114
http://dx.doi.org/10.3390/ph15030316
_version_ 1784676467818364928
author Angeli, Andrea
Kartsev, Victor
Petrou, Anthi
Lichitsky, Boris
Komogortsev, Andrey
Pinteala, Mariana
Geronikaki, Athina
Supuran, Claudiu T.
author_facet Angeli, Andrea
Kartsev, Victor
Petrou, Anthi
Lichitsky, Boris
Komogortsev, Andrey
Pinteala, Mariana
Geronikaki, Athina
Supuran, Claudiu T.
author_sort Angeli, Andrea
collection PubMed
description Carbonic anhydrases (CAs, EC 4.2.1.1) catalyze the essential reaction of CO(2) hydration in all living organisms, being actively involved in the regulation of a plethora of patho-/physiological conditions. A series of chromene-based sulfonamides were synthesized and tested as possible CA inhibitors. On the other hand, in microorganisms, the β- and γ- classes are expressed in addition to the α- class, showing substantial structural differences to the human isoforms. In this scenario, not only human but also bacterial CAs are of particular interest as new antibacterial agents with an alternative mechanism of action for fighting the emerging problem of extensive drug resistance afflicting most countries worldwide. Pyrazolo[4,3-c]pyridine sulfonamides were synthesized using methods of organic chemistry. Their inhibitory activity, assessed against the cytosolic human isoforms hCA I and hCA II, the transmembrane hCA IX and XII, and β- and γ-CAs from three different bacterial strains, was evaluated by a stopped-flow CO(2) hydrase assay. Several of the investigated derivatives showed interesting inhibition activity towards the cytosolic associate isoforms hCA I and hCA II, as well as the 3β- and 3γ-CAs. Furthermore, computational procedures were used to investigate the binding mode of this class of compounds within the active site of hCA IX. Four compounds (1f, 1g, 1h and 1k) were more potent than AAZ against hCA I. Furthermore, compound 1f also showed better activity than AAZ against the hCA II isoform. Moreover, ten compounds out of eleven appeared to be very potent against the γ-CA from E.coli, with a Ki much lower than that of the reference drug. Most of the compounds showed better activity than AAZ against hCA I as well as the γ-CA from E.coli and the β-CA from Burkholderia pseudomallei (BpsCAβ). Compounds 1f and 1k showed a good selectivity index against hCA I and hCA XII, while 1b was selective against all 3β-CA isoforms from E.coli, BpsCA, and VhCA and all 3γ-CA isoforms from E.coli, BpsCA and PgiCA.
format Online
Article
Text
id pubmed-8955975
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89559752022-03-26 Pyrazolo[4,3-c]pyridine Sulfonamides as Carbonic Anhydrase Inhibitors: Synthesis, Biological and In Silico Studies Angeli, Andrea Kartsev, Victor Petrou, Anthi Lichitsky, Boris Komogortsev, Andrey Pinteala, Mariana Geronikaki, Athina Supuran, Claudiu T. Pharmaceuticals (Basel) Article Carbonic anhydrases (CAs, EC 4.2.1.1) catalyze the essential reaction of CO(2) hydration in all living organisms, being actively involved in the regulation of a plethora of patho-/physiological conditions. A series of chromene-based sulfonamides were synthesized and tested as possible CA inhibitors. On the other hand, in microorganisms, the β- and γ- classes are expressed in addition to the α- class, showing substantial structural differences to the human isoforms. In this scenario, not only human but also bacterial CAs are of particular interest as new antibacterial agents with an alternative mechanism of action for fighting the emerging problem of extensive drug resistance afflicting most countries worldwide. Pyrazolo[4,3-c]pyridine sulfonamides were synthesized using methods of organic chemistry. Their inhibitory activity, assessed against the cytosolic human isoforms hCA I and hCA II, the transmembrane hCA IX and XII, and β- and γ-CAs from three different bacterial strains, was evaluated by a stopped-flow CO(2) hydrase assay. Several of the investigated derivatives showed interesting inhibition activity towards the cytosolic associate isoforms hCA I and hCA II, as well as the 3β- and 3γ-CAs. Furthermore, computational procedures were used to investigate the binding mode of this class of compounds within the active site of hCA IX. Four compounds (1f, 1g, 1h and 1k) were more potent than AAZ against hCA I. Furthermore, compound 1f also showed better activity than AAZ against the hCA II isoform. Moreover, ten compounds out of eleven appeared to be very potent against the γ-CA from E.coli, with a Ki much lower than that of the reference drug. Most of the compounds showed better activity than AAZ against hCA I as well as the γ-CA from E.coli and the β-CA from Burkholderia pseudomallei (BpsCAβ). Compounds 1f and 1k showed a good selectivity index against hCA I and hCA XII, while 1b was selective against all 3β-CA isoforms from E.coli, BpsCA, and VhCA and all 3γ-CA isoforms from E.coli, BpsCA and PgiCA. MDPI 2022-03-07 /pmc/articles/PMC8955975/ /pubmed/35337114 http://dx.doi.org/10.3390/ph15030316 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Angeli, Andrea
Kartsev, Victor
Petrou, Anthi
Lichitsky, Boris
Komogortsev, Andrey
Pinteala, Mariana
Geronikaki, Athina
Supuran, Claudiu T.
Pyrazolo[4,3-c]pyridine Sulfonamides as Carbonic Anhydrase Inhibitors: Synthesis, Biological and In Silico Studies
title Pyrazolo[4,3-c]pyridine Sulfonamides as Carbonic Anhydrase Inhibitors: Synthesis, Biological and In Silico Studies
title_full Pyrazolo[4,3-c]pyridine Sulfonamides as Carbonic Anhydrase Inhibitors: Synthesis, Biological and In Silico Studies
title_fullStr Pyrazolo[4,3-c]pyridine Sulfonamides as Carbonic Anhydrase Inhibitors: Synthesis, Biological and In Silico Studies
title_full_unstemmed Pyrazolo[4,3-c]pyridine Sulfonamides as Carbonic Anhydrase Inhibitors: Synthesis, Biological and In Silico Studies
title_short Pyrazolo[4,3-c]pyridine Sulfonamides as Carbonic Anhydrase Inhibitors: Synthesis, Biological and In Silico Studies
title_sort pyrazolo[4,3-c]pyridine sulfonamides as carbonic anhydrase inhibitors: synthesis, biological and in silico studies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955975/
https://www.ncbi.nlm.nih.gov/pubmed/35337114
http://dx.doi.org/10.3390/ph15030316
work_keys_str_mv AT angeliandrea pyrazolo43cpyridinesulfonamidesascarbonicanhydraseinhibitorssynthesisbiologicalandinsilicostudies
AT kartsevvictor pyrazolo43cpyridinesulfonamidesascarbonicanhydraseinhibitorssynthesisbiologicalandinsilicostudies
AT petrouanthi pyrazolo43cpyridinesulfonamidesascarbonicanhydraseinhibitorssynthesisbiologicalandinsilicostudies
AT lichitskyboris pyrazolo43cpyridinesulfonamidesascarbonicanhydraseinhibitorssynthesisbiologicalandinsilicostudies
AT komogortsevandrey pyrazolo43cpyridinesulfonamidesascarbonicanhydraseinhibitorssynthesisbiologicalandinsilicostudies
AT pintealamariana pyrazolo43cpyridinesulfonamidesascarbonicanhydraseinhibitorssynthesisbiologicalandinsilicostudies
AT geronikakiathina pyrazolo43cpyridinesulfonamidesascarbonicanhydraseinhibitorssynthesisbiologicalandinsilicostudies
AT supuranclaudiut pyrazolo43cpyridinesulfonamidesascarbonicanhydraseinhibitorssynthesisbiologicalandinsilicostudies